DEMAND, ABILITY TO PAY FOR COVID-19 VACCINE AND ASSOCIATED FACTORS OF HANOI MEDICAL UNIVERSITY STUDENTS IN 2020

Nguyen Thuy Ha1, Pham Quang Thai2, Do Thi Thanh Toan2, Nguyen Thi Thanh Hien1, Le Ngoc Trung1, Tran Ngoc Khanh Duyen1, Tran Thi Phuong Loan1, Dinh Thai Son2, Luu Ngoc Hoat2, Le Xuan Hung2, Phan Thanh Hai2, Luu Ngoc Minh2
1 Hanoi Medical University
2 Department of Research Methodology and Biostatistics, School of Preventive Medicine and Public Health, Hanoi Medical University

Main Article Content

Abstract

Background: The development of a vaccine against COVID-19 infection is on the way.
However, opinions on the implementation of the vaccine and the needs to receive the
COVID-19 vaccine vary considerably among people, which might influence the future
demand forecast and pricing considerations for COVID-19 vaccine. Objectives: This
study aims at 1) describing the demand and ability to pay, and 2) analysing factors
associated with participants; intention to utilize the COVID-19 vaccine of medical
students. Subjects and methods: We conducted a cross-sectional study among Hanoi
Medical University students. Logistic regression was used to describe the correlation
between COVID-19 vaccination needs and related factors. Linear regression was
used to describe the correlation between the ability to pay for the COVID-19 vaccine
and some associated factors. Results: Nearly 80% of the participants reported that
they were willing to get vaccinated against COVID-19 if a vaccine were available.
Factors associated with students’ needs to accept the COVID-19 vaccine included
worry about COVID-19 and the year of study of participants. The average price that
people accept to pay for a vaccine against COVID-19 is 485.25 ± 418.64 thousand
VND. Conclusion: In this study, many students aaalikely get vaccinated, and the
need to uptake COVID-19 vaccine was considered to be associated with worry of
COVID-19 and year of study.

Article Details

References

[1] Coronavirus disease (COVID-19)
– world health organization. Truy
cập ngày 15/11/2021. https://www.
who.int/emergencies/diseases/novelcoronavirus-2019
[2] Thanh Le T, Andreadakis Z, Kumar A et
al., The COVID-19 vaccine development
landscape. Nature Reviews Drug
Discovery. 2020; 19 (5): 305 – 306.
[3] COVID-19 vaccine tracker and landscape.
Truy cập ngày 15/11/2021. https://
www.who.int/publications/m/item/draftlandscape-of-covid-19-candidate-vaccines.
[4] Goldman RD, Marneni SR, Seiler M et al.,
Caregivers’ willingness to accept expedited
vaccine research during the covid-19
pandemic: a cross-sectional survey. Clin
Ther. 2020; 42 (11): 2124 – 2133.
[5] Dodd RH, Cvejic E, Bonner C et al.,
Willingness to vaccinate against COVID-19
in Australia. The Lancet Infectious
Diseases. 2021; 21 (3): 318 – 319.
[6] Lazarus JV, Ratzan SC, Palayew A et al.,
A global survey of potential acceptance
of a COVID-19 vaccine. Nat Med. 2021;
27 (2): 225 – 228.
[7] Wang J, Jing R, Lai X et al., Acceptance
of covid-19 vaccination during the
covid-19 pandemic in china. Vaccines
(Basel). 2020; 8 (3): E482.
[8] Daly M, Robinson E, Willingness to
vaccinate against covid-19 in the U.S.:
representative longitudinal evidence
from april to october 2020. American
Journal of Preventive Medicine. 2021; 60
(6): 766 – 773.
[9] Gohel KH, Patel PB, Shah PM et al.,
Knowledge and perceptions about
COVID-19 among the medical and allied
health science students in India: An
online cross-sectional survey. Clinical
Epidemiology and Global Health, 2021;
9: 104 – 109.
[10] Neumann-Böhme S, Varghese NE, Sabat
I et al., Once we have it, will we use it?
A European survey on willingness to
be vaccinated against COVID-19. Eur J
Health Econ. 2020; 21 (7): 977 – 982.